Ionis Pharmaceuticals Inc (IONS) Company Profile & Statistics

Ionis Pharmaceuticals Inc
IONS
(Nasdaq - US)
Closed
40.66
-0.15 (-0.37%)
in:usd•As of: Apr 19, 2024 15:59 UTC -4
Open
40.88
High
41.14
Low
40.40

About Ionis Pharmaceuticals Inc

CEO

Brett P. Monia

Headquarters

2855 gazelle court

carlsbad, ca 92010, united states

Auditor

Ernst & Young LLP

Employees

927

Share Holders

476

Website

http://www.ionispharma.com

Industry

pharmaceuticals major

Sector

health technology

Company Overview

Ionis Pharmaceuticals discovers/develops RNA-targeted therapeutics using its proprietary antisense oligonucleotide technology. Its antisense medicines have been developed/are being developed to treat neurological, cardiovascular and specialty rare diseases.

Ionis Pharmaceuticals Inc Statistics

Valuation Measures

Market Capitalization ²	5.93B
Enterprise Value	6.80B
Enterprise Value/EBITDA (ttm)	-19.22
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	15.18
Price to Sales (ttm)	7.57
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	98.79%
Operating Margin (ttm)	-46.32%
Profit Margin (ttm)	-61.40%
Return on Equity (ttm)	-90.29%
Return on Invested Capital (ttm)	-22.18%
Return on Assets (ttm)	-12.39%

Income Statement

Revenue (ttm)	787.65M
Revenue Per Share (ttm)	5.40
Gross Profit (ttm)	778.51M
EBITDA (ttm)³	-353.79M
Net Income Avi to Common (ttm)	-366.29M
Diluted EPS (ttm)	-2.56

Share Statistics

Beta (5Y Monthly)	0.39
52-Week Change	12.54%
S&P500 52-Week Change	20.28%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	145.75M
Dividend Yield	0.00%
Float ⁴	141.89M
% Held by Insiders	2.65%
% Held by Institutions	93.86%

Balance Sheet

Total Cash (mrq)	2.33B
Total Cash Per Share (mrq)	15.99
Total Debt (mrq)	1.27B
Total Debt/Equity (mrq)	329.42%
Current Ratio (mrq)	5.90%
Quick Ratio (mrq)	5.83%
Book Value Per Share (mrq)	2.68

Cash Flow

Operating Cash Flow Per Share (ytd)	-2.15
Free Cash Flow (ytd)	-331.30M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Ionis Pharmaceuticals Inc

Trade With A Regulated Broker